Eleven new furostanol saponins, typaspidosides B-L (1-11), one new spirostanol saponin, typaspidoside M (12), and five known spirostanol saponins, 25S-atropuroside (13), neoaspidistrin (14), (25S)-pratioside D 1 (15), 25S-aspidistrin (16) and 25S-neosibiricoside (17) were isolated from the rhizomes of Aspidistra typica Baill. The structures of the new compounds were established using 1D and 2D NMR ( 1 H-1 H COSY, HMQC, HMBC and ROESY) spectroscopy, high resolution mass spectrometry, and chemical methods. The aglycones of 1-3 (unusual furostanol saponins with opened E ring type), 9 and 10 (the methoxyl substituent at C-23 position) were found, identified from natural products for the first time. Moreover, the anti-HIV activities of the isolated steroidal glycosides were assessed, and compounds 13, 14, 16 and 17 exhibited high active against HIV-1.
Introduction
Aspidistra typica Baill is a perennial herbaceous plant which belongs to the family Convallariaceae [1] . The rhizomes of A. typica, a kind of folk herbal medicine termed "Zhi Zhu Bao Dan", are used to treat fractures, congestion and snake-bite in southwestern China and northern Vietnam [2] . A wide range of steroidal saponins have been extracted from the family Convallariaceae, but no more than 30 compounds were reported from the genus Aspidistra [3] [4] [5] [6] [7] . In order to characterize the chemical composition and active steroidal saponins of A. typical, systemic phytochemical analysis on the ethanol extract of the rhizomes of A. typica was carried out, which led to the isolation and identification of twelve new steroidal saponins, including eleven furostanol saponins (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) and one spirostanol saponin (12) , along with five known spirostanol saponins, 25S-atropuroside H (13) [8] , neoaspidistrin (14) [9] , (25S)-pratioside D 1 (15) [10, 11] , 25S-aspidistrin (16) [2, 3] and 25S-neosibiricoside D (17) [12, 13] (Fig 1) . The structures of these new compounds were elucidated mainly by NMR spectroscopic and mass spectroscopic methods, and the known compounds were identified by comparing their NMR yield 5 (38.1 mg). Fr. A4 (0.28 g) was subjected to ODS silica-gel CC eluted with MeOH-H 2 O (9:11, v/v) and a total of 50 tubes were collected. Tubes 13-20 was purified by semi-preparative HPLC with MeCN-H 2 O (21:79, v/v) to yield 1 (22.6 mg) and 2 (7.5 mg). Tubes 30-34 was evaporated under reduced pressure to yield 7 (20.6 mg). Fr. A5 (8.0 g) was subjected to ODS silica-gel CC eluted with Me 2 CO-H 2 O (7:13, v/v) and a total of 135 tubes were collected. Tables 1 and 2 C NMR data of the aglycone moiety of saponins 1-6 in pyridine-d 5 . 
Acid hydrolysis of compounds 1-12
Compounds 1-12 (2.0 mg each) were treated in 2 N CF 3 COOH-H 2 O (2 mL) at 95°C for 4 h. The reaction mixture was extracted with CH 2 Cl 2 (2 ml) three times. The aqueous layer was repeatedly evaporated to dryness until neutral. Then, in the monosaccharide mixture, glucose and galactose were detected by TLC analysis on a cellulose plate using n-BuOH-EtOAc-C 5 H 5 N-H 2 O (6:1:5:4) as the developing solution and aniline-o-phthalic acid as the detection solution and were then compared with the control samples: xyloses (R f 0.56), glucose (R f 0.45) and galactose (R f 0.48). The sugar residue in pyridine (1 mL) was added to L-cysteine methyl ester hydrochloride (3.0 mg), and the mixture was kept at 60°C for 1 h. Then, HMDS-TMCS (hexamethyldisilazane-trimethylchlorosilane) (0.6 mL) was added to the reaction mixture, which was then kept at 60°C for 0. 
HIV-1 inhibition assay of compounds 1-17
293T cells ( 2×10 5 ) were co-transfected with 0.4 μg of pHIT/G and 0.6 μg of pNL-Luc-E. After 48h, the VSV-G pseudotyped viral supernatant (HIV-1) was harvested by filtration through a 0.45 μm filter and the concentration of viral capsid protein was determined by p24 antigen capture ELISA (Biomerieux). SupT1 cells were exposed to VSV-G pseudotyped HIV-1 (MOI = 1) at 37.0°C for 48 h in the absence or presence of the test compounds (Efavirenz was used as positive control). Viral infectivity was determined by measurement of luciferase activity in the infected cell using a Luciferase Assay (Promega), which was used to calculate the inhibition rate [14] . (1.14) in the HMBC spectrum and the cross-peak correlations between H-12 (δ 3.57) and H 2 -11 (δ 1.67 and 1.85) in the COSY spectrum indicated that the hydroxyl group was located at the C-12 of the aglycone. The β orientation of OH-12 was confirmed by the NOE correlations between H-12/H-9/H-14/H-11/H-17 in the ROESY spectrum [18, 19] . The α orientation of the hydroxyl group at C-22 was established by the semiketal carbon signal at δ 110.9 [20, 21] . Therefore, the structure of 5 was assigned as 26 There are sixteen aglycones in compounds 1-17, typaspidoside A1 and timosaponin H 1 [7] , and they have different oxidative levels. Compounds 1~11, typaspidoside A1 and timosaponin H 1 are furostanol saponins and 12~17 are spirostanol saponins. Compounds 13, 14 and 16 are the corresponding spirostanol type of 5, typaspidoside A1 and timosaponin H 1 , respectively. The proto-yamogenin may be the common evolutionary precursor for all compounds in this paper. Compounds 1, 2, 5 and 6 are the secondary oxidation level products of timosaponin H 1 , and 11 is a dehydroxylation product of timosaponin H 1 . Compound 7 was formed through dehydroxylation and hydroxylation from timosaponin H 1 . Compound 8 was a methylate of 7. Compounds 9 and 10 are hydroxylation and methylation products of 11. Compound 3 is the tertiary oxidation level product of timosaponin H 1 . Compounds 12, 13 and 14 are the secondary oxidation level products of 16, furthermore, 12 is a two chains saponin after glycosidation. The detail plausible biosynthetic relationship between the isolated compounds was shown in Fig 3 .
Results and Discussion
Compounds 1-17 were evaluated for anti-HIV activities using one-round infectivity assay and the results were shown in Table 5 . All test compounds exhibited anti-HIV activities to different degrees, and 9 of them inhibited viral replication by more than 50% at a concentration of 30 uM. The spirostanol saponins showed the more strong activities than furostanol saponins. Especially, 4 compounds (13, 14, 16 and 17) showed potent activities against HIV-1with >95% inhibition of viral replication, which have the potential for anti-HIV drug development and are worth to exploit further. 
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